ADD CONDITION

items per page

Ink Scribd Numbing

Last content change checked dailysee data sync status

Active ingredient
Lidocaine Hydrochloride 4 g/100 g
Other brand names
Drug classes
Amide Local Anesthetic, Antiarrhythmic
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2025
Label revision date
September 17, 2025
Active ingredient
Lidocaine Hydrochloride 4 g/100 g
Other brand names
Drug classes
Amide Local Anesthetic, Antiarrhythmic
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2025
Label revision date
September 17, 2025
Manufacturer
Prodigy Media Inc
Registration number
M017
NDC root
70171-0029

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

You can use this medication for the temporary relief of pain and itching caused by sunburns, minor cuts, insect bites, and various skin irritations. It is designed to help soothe discomfort and promote a sense of relief when you experience these common skin issues.

Uses

If you're dealing with discomfort from sunburns, minor cuts, insect bites, or skin irritations, this medication can help provide temporary relief from pain and itching. It's designed to soothe your skin and make you feel more comfortable during these minor irritations.

Rest assured, there are no known teratogenic effects (which means it doesn't cause birth defects) associated with this medication, making it a safer option for those concerned about such risks.

Dosage and Administration

If you are an adult or a child aged 2 years and older, you can apply this medication to the affected area up to 3 to 4 times a day. Make sure to follow this guideline to ensure the best results.

However, if your child is under 2 years old, it’s important not to use this medication without first consulting a physician (doctor). Always prioritize safety and seek professional advice when it comes to younger children.

What to Avoid

It's important to be aware of specific instructions regarding the use of this product. If you accidentally swallow it, seek medical help or contact a Poison Control Center immediately. This precaution is crucial for your safety.

Currently, there are no listed contraindications, controlled substance classifications, or concerns about abuse, misuse, or dependence associated with this product. However, always use it as directed and consult with a healthcare professional if you have any questions or concerns.

Side Effects

You should only use this product on the skin's surface and avoid getting it in your eyes. If your condition worsens or does not improve after 7 days, or if symptoms clear up and then return within a few days, stop using the product and consult your doctor. It's important not to apply it to wounds or damaged skin, and you should avoid using large amounts, especially on raw or blistered areas. Always follow the recommended dosage unless your doctor advises otherwise.

Warnings and Precautions

This product is for external use only, so please avoid getting it in your eyes. It's important to use it as directed and not to apply it in large amounts, especially on raw or blistered skin. If your condition worsens or if symptoms last more than 7 days, you should stop using the product and consult your doctor. Additionally, if your symptoms improve and then return within a few days, it's also a good idea to reach out to your healthcare provider.

In case the product is swallowed, seek emergency medical help immediately or contact a Poison Control Center. Always prioritize your health and safety by following these guidelines closely.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, if you suspect that you or someone else may have taken too much of a medication, it’s important to be aware of potential signs of an overdose, which can include unusual drowsiness, confusion, or difficulty breathing.

If you notice any of these symptoms, or if you have concerns about a possible overdose, seek immediate medical help. You can contact your local emergency services or go to the nearest hospital. Always keep medications out of reach of children and follow the prescribed dosage to prevent any risks.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to know that the safety of lidocaine HCL cream during pregnancy has not been established. In fact, this cream is contraindicated, meaning it should not be used during pregnancy due to potential risks to your developing baby.

Before using lidocaine HCL cream, you should consult your physician. They can provide guidance and discuss any concerns you may have regarding its use during this important time. Your health and the health of your baby are the top priority, so always seek professional advice before starting any new treatment.

Lactation Use

If you are a nursing mother considering the use of lidocaine HCL cream, you can feel reassured that there are no specific warnings or recommendations against its use while breastfeeding. Currently, there is no information available about whether this cream is passed into breast milk or if it poses any risk to your infant.

As always, it's a good idea to consult with your healthcare provider if you have any concerns or questions about using medications while breastfeeding. They can provide personalized advice based on your situation.

Pediatric Use

When using this product for children aged 2 years and older, you can apply it to the affected area up to 3 to 4 times a day. However, if your child is under 2 years old, it's important not to use this product without first consulting a physician (a medical doctor). Always keep the product out of reach of children to prevent accidental ingestion.

If the product is swallowed, seek medical help immediately or contact a Poison Control Center for assistance. Your child's safety is the top priority, so please follow these guidelines carefully.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult considering this medication, it’s important to consult with a healthcare provider. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations related to renal impairment (kidney issues) are not provided.

Always consult your healthcare provider for personalized advice and to ensure that any medications you take are safe and appropriate for your kidney health. They can help you understand how your condition may affect your treatment and what steps to take for your safety.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you differently due to your liver health.

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have regarding your liver function and how it relates to your treatment. They can help ensure that your medication is safe and effective for you.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you.

Always feel free to ask questions and share your complete list of medications and any tests you might be undergoing. This way, you can avoid any potential issues and ensure the best possible care.

Storage and Handling

To ensure the best performance and safety of your product, store it at room temperature. It's important to check the packaging before use; do not use the product if the seal is broken, as this could compromise its safety and effectiveness. Always handle the product with care to maintain its integrity.

Additional Information

You should apply this medication topically to the affected area, using it no more than 3 to 4 times a day if you are an adult or a child aged 2 years and older. If the patient is under 2 years old, it's important to consult a physician before use. Always follow these guidelines to ensure safe and effective treatment.

FAQ

What is the drug used for?

The drug is used for the temporary relief of pain and itching associated with sunburns, minor cuts, insect bites, and skin irritations.

How should I use the drug?

Adults and children 2 years of age and older should apply it to the affected area not more than 3 to 4 times daily. Children under 2 years of age should not use it and should consult a physician.

Are there any contraindications for this drug?

There are no contraindications listed, but it should not be used on wounds or damaged skin.

What should I do if the product is swallowed?

If the product is swallowed, get medical help or contact a Poison Control Center right away.

What precautions should I take while using this drug?

For external use only, avoid contact with eyes, and do not use in large quantities, particularly over raw surfaces or blistered areas.

What should I do if my condition worsens?

Stop use and ask a doctor if your condition worsens or if symptoms persist for more than 7 days.

Is this drug safe to use during pregnancy?

The safety of this drug during pregnancy has not been established, and it is contraindicated due to potential risks to the fetus.

Can nursing mothers use this drug?

There are no specific warnings or recommendations regarding the use of this drug in nursing mothers.

How should I store this drug?

Store at room temperature and do not use if the seal is broken.

Packaging Info

Below are the non-prescription pack sizes of Ink Scribd Numbing (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Ink Scribd Numbing.
Details

Drug Information (PDF)

This file contains official product information for Ink Scribd Numbing, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of pain and itching associated with sunburns, minor cuts, insect bites, and skin irritations.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, the recommended application is to the affected area not more than 3 to 4 times daily. It is important to ensure that the application is limited to the specified frequency to avoid potential adverse effects.

For children under 2 years of age, the product should not be used without consulting a physician. Healthcare professionals are advised to evaluate the necessity and safety of treatment in this age group before proceeding with any application.

Contraindications

There are no specific contraindications listed for this product. However, it is imperative to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Warnings and Precautions

For external use only, this product should be applied with caution to avoid contact with the eyes. In the event of accidental contact, immediate rinsing with water is recommended.

Healthcare professionals should advise patients to discontinue use and consult a physician if any of the following occur: the condition worsens or symptoms persist beyond 7 days; or if symptoms resolve and then recur within a few days. It is crucial to avoid the application of this product in large quantities, especially on raw surfaces or blistered areas, and to adhere strictly to the recommended daily dosage unless otherwise directed by a healthcare provider. Additionally, this product should not be applied to wounds or damaged skin.

In cases where the product is ingested, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Patients should be instructed to stop using the product and to contact their healthcare provider if they experience worsening conditions or if symptoms persist for more than 7 days, as well as if symptoms resolve and then reappear shortly thereafter.

Side Effects

Patients should be aware that the product is intended for external use only and must avoid contact with the eyes. In clinical practice, it is advised to stop use and consult a healthcare professional if the condition worsens or if symptoms persist for more than 7 days. Additionally, if symptoms resolve and then recur within a few days, medical advice should be sought.

It is important to note that the product should not be applied to wounds or damaged skin. Caution is advised against using large quantities, particularly over raw surfaces or blistered areas. Patients should adhere to the recommended daily dosage and should not exceed it unless directed by a healthcare provider.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Ink Scribd Numbing (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Ink Scribd Numbing.
Details

Pediatric Use

Pediatric patients aged 2 years and older may apply the product to the affected area no more than 3 to 4 times daily. For children under 2 years of age, the product is not recommended, and consultation with a physician is advised.

It is important to keep the product out of reach of children. In the event of accidental ingestion, medical assistance should be sought immediately, or contact a Poison Control Center.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The safety of lidocaine HCL cream during pregnancy has not been established. Due to potential risks to the fetus, lidocaine HCL cream is contraindicated in pregnancy. Healthcare professionals are advised to consult a physician before recommending this medication to pregnant patients or those planning to become pregnant.

Lactation

There are no specific warnings or recommendations regarding the use of lidocaine HCL cream in lactating mothers. Additionally, there is no information available about the potential for excretion of lidocaine in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the text. Therefore, healthcare professionals should exercise caution and consider individual patient factors when prescribing to this population. Regular monitoring of renal function may be warranted to ensure safe and effective use of the medication in patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, which may include airway management, intravenous fluids, and monitoring of vital parameters.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Consultation with a poison control center or toxicology expert may also be warranted to guide management decisions.

It is crucial to document all findings and interventions in the patient's medical record and to report any adverse events to the appropriate regulatory authorities as required.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that if the product is swallowed, it is crucial to seek medical help immediately or contact a Poison Control Center. This information is essential for ensuring patient safety and prompt action in case of accidental ingestion.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. Additionally, the product must not be used if the seal is broken, as this may compromise its safety and effectiveness. Proper handling and storage conditions are crucial to ensure the product remains suitable for use.

Additional Clinical Information

The medication is administered topically, with the recommended application frequency for adults and children aged 2 years and older being 3 to 4 times daily to the affected area. It is advised that the product not be used in children under 2 years of age without consulting a physician.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Ink Scribd Numbing, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Ink Scribd Numbing, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.